Labels:monitor | sky | window OCR: NICE-3 Prospective nonrandomized open-label study 661 pts with non- STE ACS received enoxaparin mg/kg sa q12h AS 62 325 mo 2b- 3a inhibitor of choice standaro dose PCI at discretion the treating clinician nhibito standard iscretior